Evaluation of Trastuzumab Combined with Anthracycline Drugs Using Two-dimensional Dot Tracking Technology The value of Cardiotoxicity in Patients with Breast Cance
Dong Yan, Xie Yanlin, Gan Man
Ultrasound Medicine Department of Guangzhou First People's Hospital,Guangzhou 510180,China
Abstract：Objective To explore the value of two-dimensional dot tracking technique in early monitoring left ventricular systolic function in evaluating the cardiac toxicity of patients with breast cancer after treatment with trastuzumab combined with anthracycline drugs. Methods 50 cases of postoperative breast cance,All patients were treated with trastuzumab combined with anthracycline drugs.Routine monitoring of electrocardiogram,two-dimensional echocardiography,and two-dimensional spot tracking technology before,during,and after treatment.The main outcome measures were left ventricular ejection fraction（LVEF）and overall longitudinal strain（GLS）.30 healthy volunteers served as the control group. Results （1）GLS significantly decreased in the middle and late stages of chemotherapy compared to the control group and before chemotherapy（P<0.05）;（2L）There was no significant difference in LVEF between the pre chemotherapy group and the control group in the middle and late stages of chemotherapy. Conclusions The global longitudinal strain value（GLS）measured by two-dimensional spot tracking technology can evaluate the small changes of drug induced left ventricular dysfunction in breast cancer patients after treatment,and detect the damage of myocardial function as soon as possible。
董燕, 谢艳林, 甘曼. 二维斑点追踪技术评价曲妥珠单抗联合蒽环类药物对乳腺癌患者心脏毒性的价值[J]. 哈尔滨医药, 2024, 44(2): 31-33.
Dong Yan, Xie Yanlin, Gan Man. Evaluation of Trastuzumab Combined with Anthracycline Drugs Using Two-dimensional Dot Tracking Technology The value of Cardiotoxicity in Patients with Breast Cance. journal1, 2024, 44(2): 31-33.
[1] Poterucha JT,Kutty S,Lindquist RK,et al.Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction[J].J Am Soc Echocardiogr,2012,25(7):733-740. [2] 周庆,权毅.乳腺癌患者术后化疗所致早期心脏毒性监测指标的研究[J].现代肿瘤医学,2014,22(2):342-344.doi:CNKI:SUN:SXZL.0.2014-02-032. [3] Wu L,Yao L,Zhang H,et al.A genome-wide association study identifies WT1 variant with better response to 5-fluorouracil,pirarubicin and cyclophosphamide neoadjuvant chemotherapy in breast cancer patients[J].Oncotarget,2016,7:5042-5052.doi:10.18632/oncotarget.5837. [4] DOROSHOW J H,LOCKER G Y,MYERS C E.Enzymatic Defenses of the Mouse Heart Against Reactive Oxygen Metabolites:ALTERATIONS PRODUCED BY DOXORUBICIN Find the latest version:Enzymatic Defenses of the Mouse Heart Against Reactive Oxygen Metabolites[J].1980,65(1):128-135. [5] Plana JC,Galderisi M,Barac A,et al.Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy:a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging[J].Eur Heart J Cardiovasc Imaging,2014,15(10):1063-1093. [6] 杨倩玫,郭丽萍,李慧等.超声斑点追踪技术评价肥厚型心肌病患者左房功能.中国心血管病研究,2012,10:433-436. [7] ZHANG X,HA S,WANG X,et al.Speckle tracking echocardiography:clinical applications in cardiac resynchronization therapy[J].Int J Clin Exp Med,2015,8(5):6668-6676. [8] Stoodley PW,Richards DA,Boyd A,et al.Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy[J].Eur Heart J Cardiovasc Imaging,2013,14(3):228-234. [9] 郑言言,王玲,陈剑琼,等.斑点追踪技术评价化疗对癌症患者左心功能的影响[J].中国超声医学杂志,2012,28(11):999-1002. [10] Milks MW,Velez MR,Mehta N,et al.Usefulness of integrating heart failure risk factors into impairment of global longitudinal strain to predict anthracycline related cardiac dysfunction[J].Am J Cardiol,2018,121(7):867-873.
2024, Vol. 44 
